Day Lewis secures £160m funds and targets 150 new pharmacies

Pharmacy - £160m funding facility to the Day Lewis Group - SantanderCB

A consortium of banks, including Santander, Lloyds Banking Group, RBS, HSBC and Barclays, has provided a £160m funding facility to the Day Lewis Group chemist chain. The support comes ahead of a targeted acquisition of 150 pharmacies by 2020 to add to its current portfolio of 277 sites. Day Lewis Group also said it aims to double its revenue, which was £264m in the year to the end of March 2015. The funding facility could even be extended to £210m. It will be used by Day Lewis Group to consolidate a number of sister firms as well as funding the acquisitions.


Note: News bulletin content has been provided by a third-party and is not the opinion of Santander

Other Articles

When you’re an established business, recruiting top talent in all the areas you need can seem like a never-ending challenge.


If you’re a start-up or small business, how can you put together an attractive employee package to appeal to top talent – graduate and…


Mexico is predicted to become one of the world’s top 10 economies in the next 10 or 20 years.

Stop fraud

More than one million incidents of financial fraud occurred in the first six months of 2016, according to official figures released by…

Santander’s Head of SME International Mark Collings discusses why exporting to new global markets may provide businesses with new and…

Where Next?